Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Allergan NYSE:AGN |
63,79 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Jazz Pharmaceuticals NasdaqGS:JAZZ |
12,20 B | 8,10% | 2/6 | 79,55% | -61,52% | 13,81% | UP |
|
Alkermes NasdaqGS:ALKS |
5,81 B | 18,29% | 5/6 | 17,01% | 15,65% | 23,14% | UP |
|
Glanbia ISE:GL9 |
4,19 B | 4,55% | 5/6 | 5,11% | -30,54% | 8,82% | UP |
|
Avadel Pharmaceuticals NasdaqGM:AVDL |
2,12 B | 6,52% | 3/6 | 26,48% | -64,98% | -100,00% | UP |
|
Cosmo Pharmaceuticals N.V. SWX:COPN |
1,44 B | 12,72% | 4/6 | 174,36% | -100,07% | 45,12% | UP |
|
Perrigo NYSE:PRGO |
1,46 B | -5,73% | 0/6 | -11,32% | 65,64% | 55,66% | DOWN |
|
Mallinckrodt OTCPK:MNK |
1,02 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
GH Research PLC NasdaqGM:GHRS |
0,95 B | 0,00% | 0/4 | 0,00% | 0,00% | 139,03% | UP |
|
Amarin NasdaqCM:AMRN |
0,31 B | -7,83% | 1/6 | -295,06% | -763,15% | -18,81% | DOWN |
|
Ovoca Bio AIM:OVB |
0,00 B | 0,00% | 2/2 | 0,00% | 0,00% | -100,00% | DOWN |
